Financial Distress in Advanced Cancer Patients

M.D. Anderson Cancer Center

Status: Active, not recruiting

Conditions: Locally Advanced Malignant Neoplasm; Advanced Malignant Neoplasm; Refractory Malignant Neoplasm; Recurrent Malignant Neoplasm; Metastatic Malignant Neoplasm

Treatments: Other: Medical Chart Review; Other: Quality-of-Life Assessment; Other: Questionnaire Administration

Study type: Observational

Funder types: Other; NIH

Identifiers

NCT04053517

NCI-2019-03869 (Registry Identifier)

2018-0694 (Other Identifier)

Details and patient eligibility

About

This trial studies the severity of financial distress in advanced cancer patients. The cost of cancer care can often be very expensive. Financial distress from the burdens of high costs and debt may interfere with a patient's physical symptoms and quality of life.

Full description

PRIMARY OBJECTIVES:

I. To determine the frequency of high financial distress in advanced cancer patients.

SECONDARY OBJECTIVES:

I. To determine the association between high financial distress with clinical and demographic characteristics in advanced cancer patients.

II. To determine the correlation between In Charge Financial Distress/ Financial Well-Being Scale (IFDFW) and other financial distress instruments such as Comprehensive Score for Financial Toxicity-Functional Assessment of Chronic Illness Therapy (COST-FACIT) and Edmonton Symptom Assessment Scale- Financial Distress (ESAS-FS).

III. To determine the association between high financial distress with patient symptoms in ESAS-FS and quality of life assessed by the Functional Assessment of Cancer Therapy - General (FACT-G).

OUTLINE:

Patients complete questionnaires about financial state and quality of life over 15 minutes. Patients' medical chart is also reviewed.

Enrollment: 141 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Patient must have a diagnosis of advanced cancer, as defined by recurrent disease, locally advanced disease, metastatic disease, or refractory disease
• Patients must be able to understand, read, write, and speak English
• Patients must have no clinical evidence of severe cognitive impairment (Memorial Delirium Assessment Scale score of >= 13) and should be able to consent and answer the questionnaires
• Patients must sign an informed consent

Trial design

141 participants in 1 patient group

Observational (questionnaire administration)

Description:

Patients complete questionnaires about financial state and quality of life over 15 minutes. Patients' medical chart is also reviewed.

Treatment:

Other: Questionnaire Administration

Other: Quality-of-Life Assessment

Other: Medical Chart Review